AI-generated summary
The authors randomized 140 patients with meibomian gland dysfunction to Bian-stone and moxibustion therapy or intense pulsed light and compared objective ocular surface measures and symptom scores. They report that the Bian-stone and moxibustion group showed significant improvements at 1 and 3 months, with superior symptom and eyelid neovascularization gains versus intense pulsed light at 3 months. The authors describe the therapy as promising, but the abstract does not report a control or sham comparison.
- Participants
- 140
- Who or what was studied
- Patients with meibomian gland dysfunction (140 randomized, mean age about 59 to 60 years)
- Limits stated in the abstract
- The abstract does not describe blinding, a sham control, or follow-up beyond 3 months.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ijo.cn.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.